Search research articles
Contact Us
Filters
Showing results (51-60 of 66) with videos related to
Page
of 7
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics
|
December 7, 2017
Scientific white paper on concentration-QTc modeling
Christine Garnett, Peter L Bonate, Qianyu Dang, et al.
Cancer Chemotherapy and Pharmacology
|
December 2, 2008
Plasma and cerebrospinal fluid pharmacokinetics of tasidotin (ILX-651) and its metabolites in non-human primates
Lindsay B Kilburn, Peter L Bonate, Susan M Blaney, et al.
Journal of Clinical Pharmacology
|
September 25, 2010
Safety, tolerability, and pharmacokinetics of eliglustat tartrate (Genz-112638) after single doses, multiple doses, and food in healthy volunteers
M Judith Peterschmitt, Amy Burke, Larry Blankstein, et al.
Investigational New Drugs
|
September 16, 2010
A comparison of the pharmacokinetics of the anticancer MET inhibitor foretinib free base tablet formulation to bisphosphate salt capsule formulation in patients with solid tumors
Aung Naing, Razelle Kurzrock, Laurel M Adams, et al.
Antimicrobial Agents and Chemotherapy
|
September 20, 2017
Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi
Amit V Desai, Laura L Kovanda, William W Hope, et al.
Journal of Clinical Pharmacology
|
October 22, 2004
Population pharmacokinetics of clofarabine, a second-generation nucleoside analog, in pediatric patients with acute leukemia
Peter L Bonate, Adam Craig, Paul Gaynon, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
February 4, 2016
Methods and strategies for assessing uncontrolled drug-drug interactions in population pharmacokinetic analyses: results from the International Society of Pharmacometrics (ISOP) Working Group
Peter L Bonate, Malidi Ahamadi, Nageshwar Budha, et al.
The Pediatric Infectious Disease Journal
|
May 16, 2018
Exposure-Response Analysis of Micafungin in Neonatal Candidiasis: Pooled Analysis of Two Clinical Trials
Laura L Kovanda, Thomas J Walsh, Daniel K Benjamin, et al.
Clinical Pharmacology in Drug Development
|
March 24, 2020
Pharmacokinetics and Immunogenicity of ASP0113 in CMV-Seronegative Dialysis Patients and CMV-Seronegative and -Seropositive Healthy Subjects
Peter L Bonate, Charles Van Sant, Kathy Cho, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 8, 2025
A Multiple-Model-Informed Drug-Development Approach for Optimal Regimen Selection of an Oncolytic Virus in Combination With Pembrolizumab
Akihiro Yamada, Mary P Choules, Frances A Brightman, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 66) with videos related to
Sort By:
Page
of 7
Journal of Pharmacokinetics and Pharmacodynamics
|
December 7, 2017
Scientific white paper on concentration-QTc modeling
Christine Garnett, Peter L Bonate, Qianyu Dang, et al.
Cancer Chemotherapy and Pharmacology
|
December 2, 2008
Plasma and cerebrospinal fluid pharmacokinetics of tasidotin (ILX-651) and its metabolites in non-human primates
Lindsay B Kilburn, Peter L Bonate, Susan M Blaney, et al.
Journal of Clinical Pharmacology
|
September 25, 2010
Safety, tolerability, and pharmacokinetics of eliglustat tartrate (Genz-112638) after single doses, multiple doses, and food in healthy volunteers
M Judith Peterschmitt, Amy Burke, Larry Blankstein, et al.
Investigational New Drugs
|
September 16, 2010
A comparison of the pharmacokinetics of the anticancer MET inhibitor foretinib free base tablet formulation to bisphosphate salt capsule formulation in patients with solid tumors
Aung Naing, Razelle Kurzrock, Laurel M Adams, et al.
Antimicrobial Agents and Chemotherapy
|
September 20, 2017
Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi
Amit V Desai, Laura L Kovanda, William W Hope, et al.
Journal of Clinical Pharmacology
|
October 22, 2004
Population pharmacokinetics of clofarabine, a second-generation nucleoside analog, in pediatric patients with acute leukemia
Peter L Bonate, Adam Craig, Paul Gaynon, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
February 4, 2016
Methods and strategies for assessing uncontrolled drug-drug interactions in population pharmacokinetic analyses: results from the International Society of Pharmacometrics (ISOP) Working Group
Peter L Bonate, Malidi Ahamadi, Nageshwar Budha, et al.
The Pediatric Infectious Disease Journal
|
May 16, 2018
Exposure-Response Analysis of Micafungin in Neonatal Candidiasis: Pooled Analysis of Two Clinical Trials
Laura L Kovanda, Thomas J Walsh, Daniel K Benjamin, et al.
Clinical Pharmacology in Drug Development
|
March 24, 2020
Pharmacokinetics and Immunogenicity of ASP0113 in CMV-Seronegative Dialysis Patients and CMV-Seronegative and -Seropositive Healthy Subjects
Peter L Bonate, Charles Van Sant, Kathy Cho, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 8, 2025
A Multiple-Model-Informed Drug-Development Approach for Optimal Regimen Selection of an Oncolytic Virus in Combination With Pembrolizumab
Akihiro Yamada, Mary P Choules, Frances A Brightman, et al.
Page
of 7